Key Takeaways CLB posted Q4 adjusted EPS of 21 cents on $138.3M revenues, topping consensus estimates.Production Enhancement revenues rose 8.3% to $46M, swinging to a $3M operating profit on tech adoption.CLB guided Q1 2026 revenues of $124M-$130M and EPS of 11-15 cents amid volatile markets.Core Laboratories Inc. (CLB) reported fourth-quarter 2025 adjusted earnings of 21 cents per share, which beat the Zacks Consensus Estimate of 20 cents. This can be attributed to the outperformance of the Production Enha ...

Core Laboratories (NYSE:CLB) Q4 2025 Earnings call February 05, 2026 08:30 AM ET Company ParticipantsChris Hill - CFOGwen Gresham - SVP and Head of Investor RelationsJosh Jayne - Managing DirectorLarry Bruno - Chairman and CEOConference Call ParticipantsDon Crist - Senior Research AnalystOperatorGood day, and welcome to the Core Laboratories fourth quarter and fiscal year 2025 earnings webcast and call. All participants will be in listen-only mode. Should you need assistance, please signal a conference spec ...

Core Laboratories (NYSE:CLB) Q4 2025 Earnings call February 05, 2026 08:30 AM ET Company ParticipantsChris Hill - CFOGwen Gresham - SVP and Head of Investor RelationsJosh Jayne - Managing DirectorLarry Bruno - Chairman and CEOConference Call ParticipantsDon Crist - Senior Research AnalystOperatorGood day, and welcome to the Core Laboratories fourth quarter and fiscal year 2025 earnings webcast and call. All participants will be in listen-only mode. Should you need assistance, please signal a conference spec ...

Core Laboratories (NYSE:CLB) Q4 2025 Earnings call February 05, 2026 08:30 AM ET Speaker5Good day, and welcome to the Core Laboratories fourth quarter and fiscal year 2025 earnings webcast and call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press Star, then one on your touchtone phone. To withdra ...

Core Laboratories (CLB) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.22 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +5.00%. A quarter ago, it was expected that this energy services company would post earnings of $0.19 per share when it actually produced earnings of $0.22, delivering a surprise of +15.79%.Over the last four quart ...

Exhibit 99.1 FOR IMMEDIATE RELEASE CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS: • FOURTH QUARTER REVENUE OF $138.3 MILLION, UP 3% SEQUENTIALLY AND UP 7% YEAR- OVER-YEAR HOUSTON (February 4, 2026) – Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported fourth quarter 2025 revenue of $138,300,000. Core's operating income was $15,800,000, with earnings per diluted share ("EPS") of $0.15, all in accordance with U.S. generally accepted accounting principles ("GAAP"). ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Weekly large cap, mid cap, small cap best & worst rankings. Know what sectors, industries, and stocks to buy and when to buy them. Sign up for Tomorrow's Top Stocks Today to start receiving your weekly reports now before the next move.It's been a bit since I posted updates from our weekly sector and stocks ranking. In fact, the last time we spoke was when I predicted the stock market low on April 8, 2025, citing our proprietary data. ThatLimelight Alpha Management Partners is a team of analysts powered by E ...

Core Insights - Core Laboratories Inc. (CLB) is expected to report fourth-quarter 2025 results on February 4, with a consensus estimate of earnings at 20 cents per share and revenues at $132 million [1][7]. Q3 Earnings Highlights - In the last reported quarter, CLB's adjusted earnings were 22 cents per share, exceeding the consensus estimate by 3 cents, while operating revenues reached $134.5 million, surpassing the estimate of $128 million due to increased demand for laboratory analytical and completion diagnostic services internationally [2]. Earnings Surprise History - CLB has missed the Zacks Consensus Estimate in two of the last four quarters and beat it in the other two, resulting in an average surprise of 2.58% [3]. - The consensus estimate for fourth-quarter 2025 earnings has remained unchanged over the past 30 days, indicating a year-over-year decline of 9.09%, while revenue estimates show a 2.35% increase compared to the previous year [3]. Factors Influencing Q4 Performance - CLB's revenue is anticipated to improve due to strong performance in both the Reservoir Description and Production Enhancement segments [4]. - However, rising costs are expected to impact the bottom line, with total operating expenses projected at $117.7 million, a 2.3% increase from the previous quarter, and costs of services and product sales expected to reach $108.4 million, up 2% from last quarter [5]. Earnings Prediction Model - The Zacks model does not predict an earnings beat for CLB this quarter, as the Earnings ESP is 0.00% and the company holds a Zacks Rank of 3 (Hold) [6][8].

Investors interested in Oil and Gas - Field Services stocks are likely familiar with Halliburton (HAL) and Core Laboratories (CLB) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank emphasizes companies with ...